The Gut Microbiome: A novel player in response to systemic treatment for Breast Cancer

Background: The gut microbiome is increasingly recognised in the pathogenesis and treatment of breast cancer. Emerging evidence exists to support the specific role of the gut microbiome in tumorigenesis and in mediating the response and toxicity of both chemotherapy and immunotherapy.